
*Upadacitinib
Price | Get Latest Price | |
Package | 1g | 10g |
Min. Order: | 1g |
Supply Ability: | 80kg |
Update Time: | 2025-03-10 |
Product Details
Product Name: *Upadacitinib | CAS No.: 1310726-60-3 |
Min. Order: 1g | Purity: 0.99 |
Supply Ability: 80kg | Release date: 2025/03/10 |
?Upadacitinib (CAS 1310726-60-3)?
?? ?ChemicalBook Product Profile?
?? ?Product Overview?
?Upadacitinib? (C??H??F?N?O), a ?selective JAK1 inhibitor?, has a molecular weight of ?380.37 g/mol?. This ?white crystalline powder? (≥99% purity, HPLC-validated) is widely used for ?autoimmune disease treatment?, including rheumatoid arthritis, psoriatic arthritis, and atopic dermatitis. It modulates immune responses by targeting JAK-STAT signaling pathways, reducing inflammation with minimal off-target effects. Available in ?1g/5g/100g? sealed aluminum foil packaging, stable for ?2 years? under dark, dry, and low-temperature (-20°C) storage conditions.
?Google Keywords?: Upadacitinib CAS 1310726-60-3, JAK1 Inhibitor API Supplier, High-Purity Autoimmune Drug Intermediate, GMP-Certified Pharma Raw Material
? ?Key Advantages?
?? ?Ultra-High Purity?
≥99% purity (HPLC/NMR validated) | Complies with ?EP/USP/CP? standards.
?? ?Targeted Selectivity?74-fold higher selectivity for JAK1 over JAK2/JAK3, minimizing side effects.
?? ?Stability Assurance?Maintains integrity for ?2 years? with proper storage (-20°C recommended).
?? ?Application Fields?
?Autoimmune Therapies?: Core API for oral formulations targeting rheumatoid arthritis and dermatological disorders.
?Clinical Research?: Key compound in JAK inhibitor development and clinical trials.
?Global API Supply?: Bulk production for pharmaceutical manufacturers.
?? ?Quality Certifications?
?Testing Methods?: HPLC, NMR, mass spectrometry, microbial limit testing.
?Certifications?: ?GMP?, ?ISO 9001?, and ?ICH stability guidelines? compliance.
?? ?Market Trends?
The ?global JAK inhibitor market? is projected to reach ?$15.2 billion by 2030?, growing at ?6.8% CAGR?. Upadacitinib holds ?25% of the JAK1 inhibitor segment?, with Asia-Pacific (China, India) as the dominant API production and export hub.
?? ?Contact us for COA, bulk pricing, and custom synthesis!
Company Profile Introduction
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$90.00/1KG |
VIP1Y
|
Shandong Xuhuang New material CoLTD
|
2025-02-25 | |
$0.00/1kg |
VIP1Y
|
Hebei Junhua Import and Export Co., LTD
|
2025-02-20 | |
$0.00/1g |
VIP1Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2025-01-07 | |
$0.00/1g |
VIP1Y
|
Wuhan Circle Star Chem-medical Technology Co.,Ltd
|
2025-01-03 | |
$0.00/5kg |
VIP1Y
|
Guangzhou Tosun Pharmaceutical Ltd
|
2024-12-27 | |
$0.00/25KG |
VIP5Y
|
Hebei Mujin Biotechnology Co.,Ltd
|
2024-10-22 | |
$0.00/10g |
VIP1Y
|
Cangzhou Kangrui Pharma Tech Co. Ltd.,
|
2024-10-16 | |
$0.00/10Gram |
VIP2Y
|
Hangzhou Hyper Chemicals Limited
|
2024-09-06 | |
$1.00/1kg |
VIP1Y
|
S&Y Biochem Co.,Ltd
|
2024-08-08 | |
$1.00/1g |
VIP1Y
|
Apeloa production Co.,Limited
|
2024-06-11 |
- Since: 2018-06-08
- Address: Biolake.858 high-tech avenue,Wuhan
+86-+undefined-+86 13343427080
sales@biocarchem.com